Progressive late-onset multiple sclerosis linked to greater disability in Latvian cohort
A Latvian retrospective cohort of 56 patients found that progressive late-onset multiple sclerosis was associated with more motor and sphincter ...
Tag: disease-modifying therapy
GLP-1 Drugs Like Ozempic Face a New Test: Multiple Sclerosis
A new narrative review finds that GLP-1 receptor agonists like semaglutide and tirzepatide are safe and effective for weight loss ...
Inside China’s Lecanemab Experiment: What Families Really Think of the New Alzheimer’s Drug
A new qualitative study from West China Hospital reveals how family caregivers of Alzheimer's patients in China experience lecanemab treatment, ...
Digital Symptom Tracking Reveals How Multiple Sclerosis Patients Really Fare Day to Day
A new analysis of more than 4,000 users of the German multiple sclerosis app Brisa reveals shifting treatment patterns, stable ...
From Sodium Blockers to Gene Silencing: The Treatment Revolution in Myotonic Disorders
A new review in the Journal of Neurology charts the rapid evolution of treatments for myotonic disorders, from established sodium ...
Counting the Clock: Time-to-Event Analysis Reshapes Early Parkinson’s Disease Trials
A new time-to-event analysis of early Parkinson's disease trials shows that large, clinically meaningful worsening thresholds can be detected within ...
Flu Followed by Pneumococcal Pneumonia: A Multiple Sclerosis Case Exposes Gaps in Vaccine and Blood Monitoring
A Journal of Neurology case report describes severe invasive pneumococcal pneumonia after influenza A in a multiple sclerosis patient treated ...
Stopping Ozanimod: Large Trial Follow-Up Finds Relapses Return Mildly, With No Sign of Rebound
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod, ...
Lithium Deficiency May Drive Alzheimer’s Brain Energy Failure, Review Argues
A new review in BMC Medicine proposes that endogenous lithium deficiency worsens Alzheimer's disease by undermining cerebral energy metabolism and ...
Standard MS Drugs Offer Equal Shield Against Silent Disability Worsening, Italian Registry Study Finds
A large Italian registry study finds no significant differences among four first-line multiple sclerosis therapies in protecting against relapse-independent disability ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!